⌘K
Loading ticker…
As of 2026-08-24, enVVeno Medical Corporation Common Stock (NVNO) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 41. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.2%, relative volume 1.26×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NVNO is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.1% / -10.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
NVNO appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $64K notional.
Held by 1 ETFs · $64K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $64K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NVNO Jan avg: 2.36% median: 7.60% win: 75% σ: 12.46% n: 4 2022-04-12 → 2026-07-31 | NVNO Feb avg: 7.01% median: -0.16% win: 50% σ: 26.27% n: 4 2022-04-12 → 2026-07-31 | NVNO Mar avg: -12.00% median: -14.99% win: 25% σ: 9.29% n: 4 2022-04-12 → 2026-07-31 | NVNO Apr avg: -3.09% median: -2.57% win: 40% σ: 12.47% n: 5 2022-04-12 → 2026-07-31 | NVNO May avg: -3.70% median: -9.11% win: 40% σ: 18.70% n: 5 2022-04-12 → 2026-07-31 | NVNO Jun avg: 2.68% median: 5.84% win: 60% σ: 8.63% n: 5 2022-04-12 → 2026-07-31 | NVNO Jul avg: 23.34% median: 15.54% win: 80% σ: 25.94% n: 5 2022-04-12 → 2026-07-31 | NVNO Aug avg: -11.10% median: -0.81% win: 50% σ: 51.43% n: 4 2022-04-12 → 2026-07-31 (current) | NVNO Sep avg: -7.26% median: -3.12% win: 50% σ: 22.95% n: 4 2022-04-12 → 2026-07-31 | NVNO Oct avg: -10.03% median: -9.10% win: 50% σ: 11.95% n: 4 2022-04-12 → 2026-07-31 | NVNO Nov avg: -20.22% median: -14.54% win: 0% σ: 18.24% n: 4 2022-04-12 → 2026-07-31 | NVNO Dec avg: 3.94% median: -8.23% win: 25% σ: 30.30% n: 4 2022-04-12 → 2026-07-31 |